These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30899722)

  • 1. Effects of Thyrotropin Suppression on Bone Health in Menopausal Women with Total Thyroidectomy.
    Kim EH; Jeon YK; Pak K; Kim IJ; Kim SJ; Shin S; Kim BH; Kim SS; Lee BJ; Lee JG; Goh TS; Kim K
    J Bone Metab; 2019 Feb; 26(1):31-38. PubMed ID: 30899722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy.
    Kim K; Kim IJ; Pak K; Kim SJ; Shin S; Kim BH; Kim SS; Lee BJ; Jeon YK
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4232-4240. PubMed ID: 29982711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trabecular bone score in women with differentiated thyroid cancer on long-term TSH-suppressive therapy.
    Sousa BÉCA; Silva BC; de Oliveira Guidotti T; Pires MC; Soares MMS; Kakehasi AM
    J Endocrinol Invest; 2021 Oct; 44(10):2295-2305. PubMed ID: 33730348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.
    Paggiosi MA; Debono M; Walsh JS; Peel NFA; Eastell R
    Osteoporos Int; 2020 Apr; 31(4):667-675. PubMed ID: 31993717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
    Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
    Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TBS result is not affected by lumbar spine osteoarthritis.
    Kolta S; Briot K; Fechtenbaum J; Paternotte S; Armbrecht G; Felsenberg D; Glüer CC; Eastell R; Roux C
    Osteoporos Int; 2014 Jun; 25(6):1759-64. PubMed ID: 24687386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Effect of rhPTH(1-84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis.
    Cipriani C; Pepe J; Silva BC; Rubin MR; Cusano NE; McMahon DJ; Nieddu L; Angelozzi M; Biamonte F; Diacinti D; Hans D; Minisola S; Bilezikian JP
    J Bone Miner Res; 2018 Dec; 33(12):2132-2139. PubMed ID: 30088838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
    Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of TSH Suppression on Vertebral Trabecular Bone Scores in Patients With Differentiated Thyroid Carcinoma.
    Moon JH; Kim KM; Oh TJ; Choi SH; Lim S; Park YJ; Park DJ; Jang HC
    J Clin Endocrinol Metab; 2017 Jan; 102(1):78-85. PubMed ID: 27754806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-normal free thyroxine levels are associated with low trabecular bone scores in euthyroid postmenopausal women.
    Hwangbo Y; Kim JH; Kim SW; Park YJ; Park DJ; Kim SY; Shin CS; Cho NH
    Osteoporos Int; 2016 Feb; 27(2):457-62. PubMed ID: 26252978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of trabecular bone score over bone mineral density for identification of vertebral fractures in patients with areal bone mineral density in the non-osteoporotic range.
    Nassar K; Paternotte S; Kolta S; Fechtenbaum J; Roux C; Briot K
    Osteoporos Int; 2014 Jan; 25(1):243-9. PubMed ID: 24081509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
    Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
    J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone status in glucocorticoid-treated men and women.
    Leib ES; Winzenrieth R
    Osteoporos Int; 2016 Jan; 27(1):39-48. PubMed ID: 26252975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurements of Bone Health after Thyroid-Stimulating Suppression Therapy in Postmenopausal Women with Differentiated Thyroid Carcinoma: Bone Mineral Density versus the Trabecular Bone Score.
    Chung CW; Choi HS; Kong SH; Park YJ; Park DJ; Ahn HY; Cho SW
    J Clin Med; 2021 May; 10(9):. PubMed ID: 34063726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal Women.
    Biver E; Durosier-Izart C; Chevalley T; van Rietbergen B; Rizzoli R; Ferrari S
    J Bone Miner Res; 2018 Feb; 33(2):328-337. PubMed ID: 28960489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyroid-stimulating hormone suppression after thyroidectomy for thyroid cancer on bone mineral density in postmenopausal women: a systematic review and meta-analysis.
    Kwak D; Ha J; Won Y; Kwon Y; Park S
    BMJ Open; 2021 May; 11(5):e043007. PubMed ID: 33986046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Analysis Using Trabecular Bone Score and Dual-Energy X-Ray Absorptiometry-Based 3-Dimensional Modeling in Postmenopausal Women With Primary Hyperparathyroidism.
    Arboiro-Pinel R; Mahíllo-Fernández I; Díaz-Curiel M
    Endocr Pract; 2022 Jan; 28(1):83-89. PubMed ID: 34450273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trabecular bone score improves fracture risk prediction in non-osteoporotic women: the OFELY study.
    Boutroy S; Hans D; Sornay-Rendu E; Vilayphiou N; Winzenrieth R; Chapurlat R
    Osteoporos Int; 2013 Jan; 24(1):77-85. PubMed ID: 23070481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.
    Guo CY; Weetman AP; Eastell R
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):301-7. PubMed ID: 9156039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subregional areal bone mineral density (aBMD) is a better predictor of heterogeneity in trabecular microstructure of vertebrae in young and aged women than subregional trabecular bone score (TBS).
    Vom Scheidt A; Grisolia Seifert EF; Pokrant C; Püschel K; Amling M; Busse B; Milovanovic P
    Bone; 2019 May; 122():156-165. PubMed ID: 30776500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.